Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZFAND2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FOXP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FLNA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RUFY3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BID - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDH3G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DMD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENOX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLHL20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PITRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTMR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GABPB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF264 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRF2BP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on